Results 131 to 140 of about 81,928 (305)

Nodular mastocytosis: a case study

Vestnik Dermatologii i Venerologii, 2017
A case study of nodular mastocytosis is described. Tacrolimus was used to treat skin manifestations of mastocytosis.
E. V. Pavlova, I. V. Ulitina, YU. E. Rusak, E. N. Efanova, E. N. Ivannikova   +4 more
doaj   +1 more source

Experimental and clinical study of the efficacy of medicines containing omega-3 and 6 polyunsaturated fatty acids, in the treatment of inflammatory skin diseases [PDF]

, 2018
Over the recent years, the attention of scientists regarding the search for alternative means of treatment, including local therapy, of inflammatory skin diseases, has been focused in recent years on medicines containing omega-3 and 6 polyunsaturated ...
Grebennikova, S. V., Maklyakov, Y. S.
core   +3 more sources

SEVERE OSTEOPOROSIS DUE TO SYSTEMIC MAST CELL DISEASE: SUCCESSFUL TREATMENT WITH INTERFERON ALPHA-2B [PDF]

, 2017
We describe a 33-yr-old man suffering from severe vertebral osteoporosis and urticaria pigmentosa due to systemic mast cell disease (SMCD). Because i.v.
BEYELER, C., DAHINDEN, C., GERBER, N. J., HUNZIKER, T., LEHMANN, T., LÄMMLE, B., OLAH, A. J., VOCK, P.   +7 more
core  

Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis.

Blood Advances, 2018
Midostaurin was a prototype kinase inhibitor, originally developed as a protein kinase C inhibitor and subsequently as an angiogenesis inhibitor, based on its inhibition of vascular endothelial growth factor receptor.
R. Stone, P. Manley, R. Larson, R. Capdeville   +3 more
semanticscholar   +1 more source

Mastocytosis: One Word for Different Diseases

Oncology and Therapy, 2018
Mastocytosis is a neoplastic disease originating from tissue infiltration by transformed mast cells. The diagnosis requires a high grade of suspicion due to the large variety of presenting symptoms. The World Health Organization classification recognizes
Marianna Criscuolo, Luana Fianchi, Alessio M. E. Maraglino, Livio Pagano   +3 more
doaj   +1 more source

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

Journal of Clinical Oncology, 2019
PURPOSE To develop a risk score for patients with advanced systemic mastocytosis (AdvSM) that integrates clinical and mutation characteristics. PATIENTS AND METHODS The study included 383 patients with AdvSM from the German Registry on Disorders of ...
M. Jawhar, J. Schwaab, I. Alvarez-Twose, Khalid Shoumariyeh, N. Naumann, J. Lübke, C. Perkins, J. Muñoz-González, M. Meggendorfer, Vanessa E. Kennedy, G. Metzgeroth, A. Fabarius, D. Pfeifer, K. Sotlar, H. Horny, N. von Bubnoff, T. Haferlach, N. Cross, W. Hofmann, W. Sperr, A. García-Montero, P. Valent, J. Gotlib, A. Órfão, A. Reiter   +24 more
semanticscholar   +1 more source

Cutaneous and Gastrointestinal Symptoms in Two Patients with Systemic Mastocytosis Successfully Treated with Omalizumab

Case Reports in Medicine, 2015
The pathogenesis of mastocytosis is not well defined and thus treatment remains challenging and remains on a palliative basis. We present two cases (a 48-year-old woman and a 57-year-old man) with indolent systemic mastocytosis in whom omalizumab (anti ...
Sofie Lieberoth, Simon Francis Thomsen
doaj   +1 more source

Systemic Mastocytosis - a Diagnostic Challenge [PDF]

, 2014
Mastocytosis refers to a group of disorders characterized by the infiltration of clonally derived mast cells to the skin or extracutaneous tissues resulting in a heterogeneous clinical picture. It is a rare hematologic disorder in all its forms.
Galzerano, A, Lladó, AC, Mihon, C, Silva, M   +3 more
core  

Difficulties of primary diagnosis in patients with suspected systemic mastocytosis

Онкогематология
Background. Mastocytosis is a rare myeloproliferative disease based on clonal hematopoiesis of mast cells, with accumulation of mast cells in various tissues and organs.
Z. K. Abdulkhalikova, M. V. Barabanshchikova, V. V. Baykov, I. M. Barkhatov, E. V. Morozova, I. S. Moiseev   +5 more
doaj   +1 more source

Diffuse large B cell lymphoma coexistence with systemic mastocytosis

Journal of Cancer Research and Practice, 2016
Systemic mastocytosis is a rare disease and characterized by excessive mast cell accumulation in one or multiple organs. One subtype of systemic mastocytosis is systemic mastocytosis-associated clonal hematological non-mast cell lineage disease (SM-AHMND)
Sheng-Hsuan Chien, Yao-Chung Liu, Ying-Chung Hong, Ching-Fen Yang, Chun-Yu Liu, Tzeon-Jye Chiou, Cheng-Hwai Tzeng, Jin-Hwang Liu, Jyh-Pyng Gau   +8 more
doaj   +1 more source